1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GAMMA KNIFE MARKET BY DISEASE
5.1. Introduction
5.2. Brain Metastasis
5.3. Cancer
5.4. Arteriovenous Malformation
5.5. Trigeminal Neuralgia
5.6. Others
6. GAMMA KNIFE MARKET BY ANATOMY
6.1. Introduction
6.2. Head
6.3. Neck
6.4. Others
7. GAMMA KNIFE MARKET BY DISTRIBUTION CHANNEL
7.1. Introduction
7.2. Online
7.3. Offline
8. GAMMA KNIFE MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Elekta
10.2. Bionity
10.3. Mayo Clinic
10.4. Beaumont Health
10.5. Intermountain Healthcare
10.6. Karolinska
10.7. Allina Health
10.8. Riverside Health Systems
10.9. Varian Medical Systems
10.10. Akesis Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES